Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:RARX

Ra Pharmaceuticals (RARX) Stock Price, News & Analysis

Ra Pharmaceuticals logo

About Ra Pharmaceuticals Stock (NASDAQ:RARX)

Advanced Chart

Key Stats

Today's Range
$47.99
$47.99
50-Day Range
$47.99
$48.00
52-Week Range
$19.64
$48.02
Volume
30,200 shs
Average Volume
1.16 million shs
Market Capitalization
$2.27 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RARX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ra Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

RARX Stock News Headlines

RA: Discount Continues To Leave Some Opportunity
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
RARX_old Historical Data
See More Headlines

RARX Stock Analysis - Frequently Asked Questions

Ra Pharmaceuticals Inc (NASDAQ:RARX) released its earnings results on Thursday, February, 27th. The company reported ($0.79) EPS for the quarter, missing analysts' consensus estimates of ($0.63) by $0.16.

Ra Pharmaceuticals (RARX) raised $75 million in an initial public offering (IPO) on Wednesday, October 26th 2016. The company issued 5,800,000 shares at $12.00-$14.00 per share. Credit Suisse, Jefferies and BMO Capital Markets acted as the underwriters for the IPO and SunTrust Robinson Humphrey was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ra Pharmaceuticals investors own include Corbus Pharmaceuticals (CRBP), Viking Therapeutics (VKTX), Gilead Sciences (GILD), Verastem (VSTM), Amarin (AMRN), Bausch Health Cos (BHC) and Galmed Pharmaceuticals (GLMD).

Company Calendar

Last Earnings
2/27/2020
Today
7/06/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:RARX
Fax
N/A
Employees
72
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$102.69 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3 million
Price / Cash Flow
N/A
Book Value
$5.56 per share
Price / Book
8.63

Miscellaneous

Free Float
N/A
Market Cap
$2.27 billion
Optionable
Optionable
Beta
1.05
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:RARX) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners